Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia

Autor: Sun, Shan-Liang, Wu, Jia-Zhen, Wang, Jing-Jing, Zhou, Hai, Zhang, Chen-Qian, Tong, Zhen-Jiang, Wang, Yi-Bo, Sha, Jiu-Kai, Wang, Qing-Xin, Liu, Jia-Chuan, Zheng, Xin-Rui, Li, Qing-Qing, Zhang, Meng-Yuan, Yang, Jin, Wei, Tian-Hua, Wang, Zi-Xuan, Yu, Yan-Cheng, Ding, Ning, Leng, Xue-Jiao, Xue, Xin, Li, He-Min, Dai, Wei-Chen, Yin, Xiao-Ying, Yang, Ye, Duan, Jin-Ao, Li, Nian-Guang, Shi, Zhi-Hao
Zdroj: In Biomedicine & Pharmacotherapy 31 December 2023 169
Databáze: ScienceDirect
Externí odkaz: